AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie scope 1 Office Activities GHG Emissions (tCO2e)
AbbVie ESG Action Reports
Latest, FY2025
2,889.00
Period ended Dec 31, 2025
Change on a year earlier
-38.6%
4,708.00 in FY2024
History
5 years
Since FY2021
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 1 Office Activities GHG Emissions (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,889.00 | -38.6% | AbbVie 2025 ESG Action Report ↗ |
| FY2024 | Dec 31, 2024 | 4,708.00 | -5.9% | AbbVie 2025 ESG Action Report ↗ |
| FY2023 | Dec 31, 2023 | 5,002.00 | -7.9% | AbbVie 2025 ESG Action Report ↗ |
| FY2022 | Dec 31, 2022 | 5,432.00 | -8.3% | AbbVie 2023 ESG Action Report ↗ |
| FY2021 | Dec 31, 2021 | 5,921.00 | – | AbbVie 2023 ESG Action Report ↗ |
Cite this data
StockData. (2026). AbbVie Scope 1 Office Activities GHG Emissions (tCO2e), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/esg_scope1_off
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.